Lyme disease prevention program launched in ConnecticutAugust 15, 2005New Haven, Conn. - Researchers at the Emerging Infections Program (EIP) at Yale School of Medicine in partnership with the Connecticut Department of Public Health and the Centers for Disease Control and Prevention have launched a Lyme disease prevention study in 21 Connecticut communities. The goal of the program is to evaluate the effectiveness of personal protective measures and landscape modification practices on Lyme disease risk. The 21 communities are located in the Torrington Area, Westport-Weston, and Ledge Light Health Districts. To be eligible for the study, residents must have a yard and have been diagnosed with a Lyme disease rash within the past year. "Results of the study will help us understand which prevention behaviors are most effective for preventing Lyme disease," said EIP researcher Neeta Pardanani, who will conduct the study with James Meek, associate director of the EIP in the Department of Epidemiology and Public Health at Yale School of Medicine. \\\
Yale University | |||||||||||||||||||||
|
Related Lyme Disease Current Events and Lyme Disease News Articles Study: Bird diversity lessens human exposure to West Nile Virus A study by biologists at Washington University in St. Louis shows that the more diverse a bird population is in an area, the less chance humans have of exposure to West Nile Virus (WNV). 'Deadly dozen' reports diseases worsened by climate change Health experts from the Wildlife Conservation Society today released a report that lists 12 pathogens that could spread into new regions as a result of climate change, with potential impacts to both human and wildlife health and global economies. UCR researchers propose minocycline as a promising drug for patients with Fragile X syndrome A UC Riverside-led team of biomedical scientists has found that a readily available drug called minocycline, used widely to treat acne and skin infections, can be used to treat Fragile X syndrome, the most common inherited cause of mental impairment and the most common cause of autism. Diversity among bird populations found to reduce threat of West Nile virus A biologist and undergraduate student have discovered that what's good for an area's bird population is also good for people living nearby. Researchers track Lyme disease spirochetes Microbiologists at the University of Calgary have demonstrated the first direct visualization of the dissemination of Borrelia burgdorferi, the bacterium that causes Lyme disease. Drug prevents dangerous tick diseases Lyme disease is the blight of countryside users but it may be prevented with a single injection, according to research published in the Journal of Medical Microbiology. University of Pennsylvania Study Reveals Inconspicuous Hosts in the Lyme Disease Epidemic A study led by a University of Pennsylvania biologist in the tick-infested woods of the Hudson Valley is challenging the widely held belief that mice are the main animal reservoir for Lyme disease in the U.S. First placebo-controlled study of cognitive impairment due to chronic Lyme disease Findings from the first placebo-controlled study of chronic cognitive impairment after treated Lyme disease (also known as chronic Lyme encephalopathy) demonstrate that patients report moderate cognitive impairment, physical dysfunction comparable to patients with congestive heart failure, and fatigue comparable to patients with multiple sclerosis. Water, air and soil pollution causes 40 percent of deaths worldwide, Cornell research survey finds About 40 percent of deaths worldwide are caused by water, air and soil pollution, concludes a Cornell researcher. Such environmental degradation, coupled with the growth in world population, are major causes behind the rapid increase in human diseases, which the World Health Organization has recently reported. "Combination" Lyme Disease Vaccine Proteins Patented Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and collaborators at Stony Brook University have received U.S. Patent Number 7,179,448 for developing chimeric, or "combination," proteins that may advance the development of vaccines and diagnostic tests for Lyme disease. More Lyme Disease Current Events and Lyme Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||